The absence of the drhm gene is not a marker for human-pathogenicity in European Anaplasma phagocytophilum strains.
APH_0919
APH_0922
Anaplasma phagocytophilum
Asia
Europe
Human
Multilocus sequence typing (MLST)
North America
Pathogenicity
ankA
drhm
Journal
Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774
Informations de publication
Date de publication:
07 May 2020
07 May 2020
Historique:
received:
18
02
2020
accepted:
29
04
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
7
1
2021
Statut:
epublish
Résumé
Anaplasma phagocytophilum is a Gram-negative obligate intracellular bacterium that replicates in neutrophil granulocytes. It is transmitted by ticks of the Ixodes ricinus complex and causes febrile illness in humans and animals. The geographical distribution of A. phagocytophilum spans the Americas, Europe, Africa and Asia. However, human disease predominantly occurs in North America but is infrequently reported from Europe and Asia. In North American strains, the absence of the drhm gene has been proposed as marker for pathogenicity in humans whereas no information on the presence or absence of the drhm gene was available for A. phagocytophilum strains circulating in Europe. Therefore, we tested 511 European and 21 North American strains for the presence of drhm and compared the results to two other typing methods: multilocus sequence typing (MLST) and ankA-based typing. Altogether, 99% (478/484) of the analyzable European and 19% (4/21) of the North American samples from different hosts were drhm-positive. Regarding the strains from human granulocytic anaplasmosis cases, 100% (35/35) of European origin were drhm-positive and 100% (14/14) of North American origin were drhm-negative. Human strains from North America and Europe were both part of MLST cluster 1. North American strains from humans belonged to ankA gene clusters 11 and 12 whereas European strains from humans were found in ankA gene cluster 1. However, the North American ankA gene clusters 11 and 12 were highly identical at the nucleotide level to the European cluster 1 with 97.4% and 95.2% of identity, respectively. The absence of the drhm gene in A. phagocytophilum does not seem to be associated with pathogenicity for humans per se, because all 35 European strains of human origin were drhm-positive. The epidemiological differences between North America and Europe concerning the incidence of human A. phagocytophilum infection are not explained by strain divergence based on MLST and ankA gene-based typing.
Sections du résumé
BACKGROUND
BACKGROUND
Anaplasma phagocytophilum is a Gram-negative obligate intracellular bacterium that replicates in neutrophil granulocytes. It is transmitted by ticks of the Ixodes ricinus complex and causes febrile illness in humans and animals. The geographical distribution of A. phagocytophilum spans the Americas, Europe, Africa and Asia. However, human disease predominantly occurs in North America but is infrequently reported from Europe and Asia. In North American strains, the absence of the drhm gene has been proposed as marker for pathogenicity in humans whereas no information on the presence or absence of the drhm gene was available for A. phagocytophilum strains circulating in Europe. Therefore, we tested 511 European and 21 North American strains for the presence of drhm and compared the results to two other typing methods: multilocus sequence typing (MLST) and ankA-based typing.
RESULTS
RESULTS
Altogether, 99% (478/484) of the analyzable European and 19% (4/21) of the North American samples from different hosts were drhm-positive. Regarding the strains from human granulocytic anaplasmosis cases, 100% (35/35) of European origin were drhm-positive and 100% (14/14) of North American origin were drhm-negative. Human strains from North America and Europe were both part of MLST cluster 1. North American strains from humans belonged to ankA gene clusters 11 and 12 whereas European strains from humans were found in ankA gene cluster 1. However, the North American ankA gene clusters 11 and 12 were highly identical at the nucleotide level to the European cluster 1 with 97.4% and 95.2% of identity, respectively.
CONCLUSIONS
CONCLUSIONS
The absence of the drhm gene in A. phagocytophilum does not seem to be associated with pathogenicity for humans per se, because all 35 European strains of human origin were drhm-positive. The epidemiological differences between North America and Europe concerning the incidence of human A. phagocytophilum infection are not explained by strain divergence based on MLST and ankA gene-based typing.
Identifiants
pubmed: 32381072
doi: 10.1186/s13071-020-04116-z
pii: 10.1186/s13071-020-04116-z
pmc: PMC7206706
doi:
Substances chimiques
Genetic Markers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
238Commentaires et corrections
Type : ErratumIn
Références
Microbiology (Reading). 2004 Mar;150(Pt 3):727-734
pubmed: 14993322
J Clin Microbiol. 2013 Jun;51(6):1958-61
pubmed: 23576542
Pathogens. 2014 Jan 09;3(1):25-35
pubmed: 25437606
J Clin Microbiol. 2011 Nov;49(11):3997-4000
pubmed: 21918028
Clin Lab Med. 2017 Jun;37(2):317-340
pubmed: 28457353
Am J Trop Med Hyg. 2013 Mar;88(3):510-2
pubmed: 23339197
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6209-14
pubmed: 8650245
Vet Microbiol. 2015 Aug 5;178(3-4):246-51
pubmed: 26051478
Parasitol Res. 2015 Nov;114(11):3941-57
pubmed: 26346451
J Clin Microbiol. 2011 Mar;49(3):790-6
pubmed: 21177886
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Vet Microbiol. 2010 Aug 26;144(3-4):405-8
pubmed: 20558015
J Clin Microbiol. 2007 Jun;45(6):1771-6
pubmed: 17442796
N Engl J Med. 2011 Apr 21;364(16):1523-32
pubmed: 21410387
Parasit Vectors. 2019 Dec 21;12(1):599
pubmed: 31864403
PLoS Negl Trop Dis. 2019 Sep 20;13(9):e0007728
pubmed: 31539395
PLoS Pathog. 2011 Nov;7(11):e1002369
pubmed: 22114553
Emerg Infect Dis. 2016 Oct;22(10):1728-31
pubmed: 27648639
Trop Anim Health Prod. 2013 Oct;45(7):1557-61
pubmed: 23553260
Int J Syst Evol Microbiol. 2001 Nov;51(Pt 6):2145-2165
pubmed: 11760958
Ticks Tick Borne Dis. 2018 Mar;9(3):543-555
pubmed: 29398602
PLoS One. 2013;8(2):e57155
pubmed: 23451170
J Clin Microbiol. 2003 Apr;41(4):1569-73
pubmed: 12682147
Parasit Vectors. 2018 Mar 9;11(1):163
pubmed: 29523202
PLoS One. 2009 Dec 15;4(12):e8265
pubmed: 20016821
Front Cell Infect Microbiol. 2015 Aug 14;5:61
pubmed: 26322277
Parasit Vectors. 2017 Aug 7;10(1):377
pubmed: 28784148
Ticks Tick Borne Dis. 2019 Aug;10(5):1051-1056
pubmed: 31171465
Parasit Vectors. 2014 Aug 15;7:365
pubmed: 25127547
Parasit Vectors. 2020 Mar 30;13(1):157
pubmed: 32228658
J Clin Microbiol. 1995 Dec;33(12):3333-4
pubmed: 8586731
Front Cell Infect Microbiol. 2013 Jul 22;3:31
pubmed: 23885337
Microb Pathog. 2018 Jun;119:1-8
pubmed: 29626656
Vet Rec. 1999 Sep 11;145(11):311-4
pubmed: 10515618
Infect Genet Evol. 2020 Jun;80:104234
pubmed: 32028054
J Clin Microbiol. 2007 Jul;45(7):2138-43
pubmed: 17475757
PLoS One. 2014 Apr 03;9(4):e93725
pubmed: 24699849
J Clin Microbiol. 2003 Nov;41(11):5033-40
pubmed: 14605135
Emerg Infect Dis. 2009 Dec;15(12):1948-54
pubmed: 19961674
Parasit Vectors. 2019 Jun 28;12(1):328
pubmed: 31253201
Vet Parasitol. 2018 Apr 30;254:26-29
pubmed: 29657007
J Vet Intern Med. 2009 Nov-Dec;23(6):1129-41
pubmed: 19761477
Infect Immun. 1998 Apr;66(4):1356-63
pubmed: 9529053
BMC Vet Res. 2013 Nov 28;9:235
pubmed: 24283328
Infect Ecol Epidemiol. 2020 Mar 15;10(1):1729653
pubmed: 32284823
Emerg Infect Dis. 2013 Feb;19(2):289-92
pubmed: 23460988
Med Vet Entomol. 1998 Oct;12(4):423-9
pubmed: 9824827
Ticks Tick Borne Dis. 2016 Mar;7(2):390-3
pubmed: 26748871
J Clin Microbiol. 1999 Sep;37(9):2887-92
pubmed: 10449470
Vector Borne Zoonotic Dis. 2011 Mar;11(3):223-9
pubmed: 20846015
Emerg Infect Dis. 2014 Oct;20(10):1708-11
pubmed: 25271737
Vet Parasitol. 2010 Feb 10;167(2-4):108-22
pubmed: 19811878